SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

MaxCyte Reports Q3 Adjusted EBITDA of -$5.1 Million

MaxCyte reported Q3 net income of -$4.8 million. Adjusted EBITDA was -$5.1 million versus an IBES estimate of -$7.99 million.

MXCT

Related stories